Technical Analysis for FBIO - Fortress Biotech, Inc.

Grade Last Price % Change Price Change
grade C 1.86 -6.06% -0.12
FBIO closed down 6.06 percent on Friday, March 22, 2019, on 44 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Up Down
See historical FBIO trend table...

Date Alert Name Type % Chg
Mar 22 Bollinger Band Squeeze Range Contraction 0.00%
Mar 21 Bearish Engulfing Bearish -6.06%
Mar 21 Fell Below 20 DMA Bearish -6.06%
Mar 21 Golden Cross Bullish -6.06%
Mar 21 Bollinger Band Squeeze Range Contraction -6.06%
Mar 21 BB Squeeze Started Range Contraction -6.06%
Mar 20 Crossed Above 20 DMA Bullish -13.49%
Mar 20 Pocket Pivot Bullish Swing Setup -13.49%
Mar 19 20 DMA Resistance Bearish -6.53%
Mar 18 20 DMA Resistance Bearish -6.53%

Older signals for FBIO ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Fortress Biotech, Inc., a biopharmaceutical company, develops novel immunotherapy agents for the treatment of autoimmune diseases and cancer. The company's principal pharmaceutical product candidates in clinical development include Trichuris suis ova or CNDO-201, a biologic comprising the microscopic eggs of the porcine whipworm for the treatment of autoimmune diseases, such as Crohn's disease, ulcerative colitis, or autism spectrum disorder; and CNDO-109, a biologic that activates the immune system's natural killer cells to seek and destroy cancer cells for the treatment of acute myeloid leukemia. It has strategic alliances and commercial agreements with Ovamed GmbHp; Dr. Falk Pharma GmbH; and Freie Universität Berlin. The company was formerly known as Coronado Biosciences, Inc. and changed its name to Fortress Biotech, Inc. in April 2015. Fortress Biotech, Inc. was founded in 2006 and is based in Burlington, Massachusetts.
Medicine Biotechnology Biopharmaceutical Cancer Medical Specialties Clinical Medicine Immunology Immunotherapy Autoimmune Diseases Acute Myeloid Leukemia Ulcerative Colitis Abdominal Pain Crohn's Disease Treatment Of Acute Myeloid Leukemia Treatment Of Autoimmune Diseases
Is FBIO a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 2 bullish, 0 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 5.22
52 Week Low 0.49
Average Volume 636,749
200-Day Moving Average 1.794
50-Day Moving Average 1.8228
20-Day Moving Average 1.978
10-Day Moving Average 1.966
Average True Range 0.1922
ADX 22.76
+DI 22.0128
-DI 16.8897
Chandelier Exit (Long, 3 ATRs ) 1.6334
Chandelier Exit (Short, 3 ATRs ) 2.2666
Upper Bollinger Band 2.2476
Lower Bollinger Band 1.7084
Percent B (%b) 0.28
BandWidth 27.259858
MACD Line 0.0237
MACD Signal Line 0.0386
MACD Histogram -0.0149
Fundamentals Value
Market Cap 93.98 Million
Num Shares 50.5 Million
EPS -1.48
Price-to-Earnings (P/E) Ratio -1.26
Price-to-Sales 1.68
Price-to-Book 2.53
PEG Ratio -0.08
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 2.05
Resistance 3 (R3) 2.07 2.02 2.02
Resistance 2 (R2) 2.02 1.97 2.01 2.01
Resistance 1 (R1) 1.94 1.94 1.91 1.92 2.00
Pivot Point 1.89 1.89 1.88 1.88 1.89
Support 1 (S1) 1.81 1.84 1.79 1.80 1.72
Support 2 (S2) 1.76 1.81 1.75 1.71
Support 3 (S3) 1.68 1.76 1.70
Support 4 (S4) 1.67